Flu News and Research

RSS
New testing protocol for SARS-CoV-2 can process thousands of samples within 48 hours

New testing protocol for SARS-CoV-2 can process thousands of samples within 48 hours

If you are vaccinated, you can dance the night away

If you are vaccinated, you can dance the night away

Can SARS-CoV-2 trigger amyloidosis?

Can SARS-CoV-2 trigger amyloidosis?

Methotrexate impairs immunogenicity of BNT162b2 SARS-CoV-2 vaccine in patients with immune-mediated inflammatory diseases

Methotrexate impairs immunogenicity of BNT162b2 SARS-CoV-2 vaccine in patients with immune-mediated inflammatory diseases

Researchers identify specific influenza targets that could lead to universal flu vaccine for indigenous populations

Researchers identify specific influenza targets that could lead to universal flu vaccine for indigenous populations

COVID-19 public health interventions reduced other respiratory infections

COVID-19 public health interventions reduced other respiratory infections

Milder COVID-19 in children may be due to higher memory B cells responses to SARS-CoV-2

Milder COVID-19 in children may be due to higher memory B cells responses to SARS-CoV-2

Employment for frontline healthcare workers should be conditional on COVID-19 jab, argue ethicists

Employment for frontline healthcare workers should be conditional on COVID-19 jab, argue ethicists

New method provides greater quality control and safety of heparin drug

New method provides greater quality control and safety of heparin drug

A magnetofluidic platform for SARS-CoV-2 variant and respiratory pathogen detection

A magnetofluidic platform for SARS-CoV-2 variant and respiratory pathogen detection

Pfizer-BioNTech COVID-19 vaccine effective in patients with myeloproliferative neoplasms

Pfizer-BioNTech COVID-19 vaccine effective in patients with myeloproliferative neoplasms

Inexpensive test for rapid detection of COVID-19 with 90% accuracy

Inexpensive test for rapid detection of COVID-19 with 90% accuracy

Researchers investigate antibodies that best neutralize SARS-CoV-2 in COVID-19 patients

Researchers investigate antibodies that best neutralize SARS-CoV-2 in COVID-19 patients

Novel chip-based antigen test can provide ultrasensitive detection of SARS-CoV-2, influenza A

Novel chip-based antigen test can provide ultrasensitive detection of SARS-CoV-2, influenza A

Study reveals how oral antiviral drug works to attack SARS-CoV-2 virus

Study reveals how oral antiviral drug works to attack SARS-CoV-2 virus

T cell populations in nasal mucosa expand after COVID-19 mRNA vaccination

T cell populations in nasal mucosa expand after COVID-19 mRNA vaccination

Case study describes consequences of undetected SARS-CoV-2 infection during mRNA vaccination

Case study describes consequences of undetected SARS-CoV-2 infection during mRNA vaccination

Scientists produce a universal flu vaccine using nanoparticles to induce long-lasting immunity

Scientists produce a universal flu vaccine using nanoparticles to induce long-lasting immunity

Combo COVID-flu vaccine protects against current and emerging variants in animal model

Combo COVID-flu vaccine protects against current and emerging variants in animal model

Unique infectious profile explains why it is so hard to treat COVID-19

Unique infectious profile explains why it is so hard to treat COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.